Symbol="ADXN"
AssetType="Common Stock"
Name="Addex Therapeutics Ltd"
Description="Addex Therapeutics Ltd, a developing-stage biopharmaceutical company, discovers, develops and markets small molecule pharmaceuticals for central nervous system (CNS) disorders in Switzerland. The company is headquartered in Geneva, Switzerland."
CIK="1574232"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="CHEMIN DES MINES 9, GENEVA, CH"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="9683100"
EBITDA="-17205740"
PERatio="None"
PEGRatio="None"
BookValue="0.384"
DividendPerShare="0"
DividendYield="0"
EPS="-2.34"
RevenuePerShareTTM="0.198"
ProfitMargin="0"
OperatingMarginTTM="-10.07"
ReturnOnAssetsTTM="-0.859"
ReturnOnEquityTTM="-2.042"
RevenueTTM="1703100"
GrossProfitTTM="1445000"
DilutedEPSTTM="-2.34"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.058"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="10.28"
PriceToBookRatio="1.409"
EVToRevenue="2.539"
EVToEBITDA="-0.147"
Beta="1.678"
num_52WeekHigh="2.49"
num_52WeekLow="0.422"
num_50DayMovingAverage="0.708"
num_200DayMovingAverage="0.902"
SharesOutstanding="14807100"
DividendDate="None"
ExDividendDate="None"
symbol="ADXN"
open="0.57"
high="0.60"
low="0.56"
price="0.60"
volume="18105.00"
latest_trading_day="2023-07-05"
previous_close="0.58"
change="0.02"
change_percent="2.6701%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="62"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="38"
Volume_recent_avg="444234"
Change_recent_avg="-0.01"
Delta_recent_avg="0.12"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-1.7"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="38"
Aroon_momentum_negative="62"
image_negative_thumbnail_id_1="510"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0095.jpeg"
image_negative_thumbnail_id_2="123"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0053.jpeg"
image_neutral_thumbnail_id_1="576"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0023.jpeg"
image_neutral_thumbnail_id_2="556"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0043.jpeg"
image_positive_thumbnail_id_1="692"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0016.jpeg"
image_positive_thumbnail_id_2="631"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0077.jpeg"
image_professor_thumbnail_id_1="1190"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
